发明名称 SUBSTITUTED 3−PHENYL−5−ALKOXI−1,3,4−OXDIAZOL−2−ONES AND THEIR USE AS LIPASE INHIBITORS
摘要 Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones of the formula 1in any optically isomeric form, and their physiologically acceptable salts, where R1 is C1-C6-alkyl, C3-C9-cycloalkyl, both of which may be unsubstituted or substituted, and R2 and R3 independently of one another are hydrogen, C6-C10-aryl, C3-C8-cycloalkyl, C6-C10-aryloxymethyl, O-benzyl, O-C6-C10-aryl, O-C3-C8-cycloalkyl, O-C1-C6-alkyl, SO2-NH-C1-C6-alkyl, SO2-NH-(2,2,6,6-tetramethylpiperidin-4-yl), SO2-NH-C3-C8-cycloalkyl, SO2-N(C1-C6-alkyl)2 or COX, where X is O-C1-C6-alkyl, NH-C1-C6-alkyl, NH-C3-C8-cycloalkyl or N(C1-C6-alkyl)2, with the proviso that the substitutents R2 and R3 may in some instances be unsubstituted or substituted and are not both simultaneously hydrogen. A process for their preparation, and their inhibitory effect on the hormone-sensitive lipase, HSL.
申请公布号 PL197314(B1) 申请公布日期 2008.03.31
申请号 PL20000353214 申请日期 2000.08.22
申请人 SANOFI-AVENTIS DEUTSCHLAND GMBH 发明人 PETRY STEFAN;SCHOENAFINGER KARL;MUELLER GUENTER;BARINGHAUS KARL-HEINZ
分类号 C07D271/10;C07D271/113;A61K31/4245;A61K31/454;A61K31/496;A61K31/5377;A61P3/10;A61P43/00;C07D413/10;C07D413/12 主分类号 C07D271/10
代理机构 代理人
主权项
地址